Machine learning combined with multispectral infrared imaging to guide cancer surgery

Surgical tumor removal remains one of the most common procedures during cancer treatment, with about 45% of cancer patients undergoing this surgery at some point. Thanks to recent progress in imaging and biochemical technologies, surgeons are now better able to tell tumors apart from healthy tissue. Specifically, this is enabled by a technique called “fluorescence-guided surgery” (FGS).